A PHP Error was encountered

Severity: 8192

Message: mysql_escape_string(): This function is deprecated; use mysql_real_escape_string() instead.

Filename: mysql/mysql_driver.php

Line Number: 319

A PHP Error was encountered

Severity: 8192

Message: mysql_escape_string(): This function is deprecated; use mysql_real_escape_string() instead.

Filename: mysql/mysql_driver.php

Line Number: 319

A PHP Error was encountered

Severity: 8192

Message: mysql_escape_string(): This function is deprecated; use mysql_real_escape_string() instead.

Filename: mysql/mysql_driver.php

Line Number: 319

%PDF-1.3 1 0 obj << /Type /Catalog /Outlines 2 0 R /Pages 3 0 R >> endobj 2 0 obj << /Type /Outlines /Count 0 >> endobj 3 0 obj << /Type /Pages /Kids [6 0 R ] /Count 1 /Resources << /ProcSet 4 0 R /Font << /F1 8 0 R /F2 9 0 R >> >> /MediaBox [0.000 0.000 595.280 841.890] >> endobj 4 0 obj [/PDF /Text ] endobj 5 0 obj << /Creator (DOMPDF) /CreationDate (D:20210612220548+03'00') /ModDate (D:20210612220548+03'00') >> endobj 6 0 obj << /Type /Page /Parent 3 0 R /Annots [ 16 0 R 18 0 R ] /Contents 7 0 R >> endobj 7 0 obj << /Length 4745 >> stream 0.000 0.000 0.000 rg BT 58.016 774.681 Td /F2 12.0 Tf [(Tecentriq, Xeljanz ve Aminoglikozidler ile 0lgili Haz1rlanan Doktor Bilgilendirme Mektuplar1 )] TJ ET BT 52.016 755.688 Td /F2 12.0 Tf [(Hakk1nda )] TJ ET BT 58.016 736.696 Td /F2 12.0 Tf [(42.A.00/12550)] TJ ET BT 58.016 711.704 Td /F2 12.0 Tf [(14/04/2021)] TJ ET BT 58.016 686.712 Td /F2 12.0 Tf [(BLGE ECZACI ODASI)] TJ ET BT 58.016 661.720 Td /F2 12.0 Tf [(YNET0M KURULU BA^KANLII NA)] TJ ET BT 58.016 636.728 Td 1.760 Tw /F2 12.0 Tf [(T.C. ) -147 (Sal1k ) -147 (Bakanl11 ) -147 (Trkiye ) -147 (0la ) -147 (ve ) -147 (T1bbi ) -147 (Cihaz ) -147 (Kurumu ) -147 (taraf1ndan, ) -147 (sal1k ) -147 (meslei ) -147 (mensuplar1n1n ) -147 (ila ) -147 ()] TJ ET BT 58.016 617.735 Td 4.862 Tw /F2 12.0 Tf [(gvenilirlii ) -405 (ile ) -405 (ilgili ) -405 (konularda ) -405 (meydana ) -405 (gelen ) -405 (geli_melerden ) -405 (ivedilikle ) -405 (haberdar ) -405 (olmalar1n1 ) -405 ()] TJ ET BT 58.016 598.743 Td 0.000 Tw /F2 12.0 Tf [(salamak amac1yla yrtlen mektup da1t1lmas1 uygulamas1 kapsam1nda,)] TJ ET BT 64.016 573.751 Td 6.464 Tw /F2 12.0 Tf [( ) -539 (Tecentriq ) -539 (\(atezolizumab\): ) -539 (_iddetli ) -539 (kutanz ) -539 (advers ) -539 (reaksiyonlar ) -539 (\(SCAR ) -539 (lar\) ) -539 (riski ) -539 (, ) -539 ( ) -539 (Xeljanz ) -539 ()] TJ ET BT 58.016 554.759 Td 1.487 Tw /F2 12.0 Tf [(\(tofacitinib\): ) -124 (TNF-Alfa ) -124 (inhibitrleri ) -124 (tedavisine ) -124 (k1yasla ) -124 (tofasitinib ) -124 (kullan1m1yla ) -124 (artan ) -124 (majr ) -124 (advers ) -124 ()] TJ ET BT 58.016 535.767 Td 6.788 Tw /F2 12.0 Tf [(kardiyovaskler ) -566 (olaylar ) -566 (ve ) -566 (maligniteler ) -566 (\(Melanom ) -566 (D1_1 ) -566 (Deri ) -566 (Kanserleri ) -566 (Hari\) ) -566 (riski ) -566 ( ) -566 (ile ) -566 ()] TJ ET BT 58.016 516.775 Td 2.070 Tw /F2 12.0 Tf [( ) -172 (Aminoglikozidler ) -172 (\(gentamisin, ) -172 (amikasin, ) -172 (tobramisin ) -172 (ve ) -172 (neomisin\): ) -172 (mitokondriyal ) -172 (mutasyonlar1 ) -172 ()] TJ ET BT 58.016 497.782 Td 5.277 Tw /F2 12.0 Tf [(olan ) -440 (hastalarda ) -440 (artm1_ ) -440 (sa1rl1k ) -440 (riski ) -440 ( ) -440 ()] TJ ET BT 247.901 497.782 Td 5.277 Tw /F2 12.0 Tf [(ba_l1klar1 ) -440 (ile ) -440 (da1t1m1 ) -440 (Kurum ) -440 (taraf1ndan ) -440 (onaylanan ) -440 (doktor ) -440 ()] TJ ET BT 58.016 478.790 Td 0.000 Tw /F2 12.0 Tf [(bilgilendirme mektuplar1n1n Birliimiz taraf1ndan duyurulmas1 istenmektedir.)] TJ ET BT 58.016 453.798 Td 1.089 Tw /F2 12.0 Tf [(0lgili ) -91 (Kurum ) -91 (yaz1s1 ) -91 (ve ) -91 (doktor ) -91 (bilgilendirme ) -91 (mektuplar1 ) -91 (yaz1m1z ) -91 (ekinde ) -91 (yer ) -91 (almakta ) -91 (olup, ) -91 (bilgilerinizi ) -91 ()] TJ ET BT 58.016 434.806 Td 0.000 Tw /F2 12.0 Tf [(ve konu hakk1nda yelerinizin bilgilendirilmesini sayg1lar1mla rica ederim.)] TJ ET BT 58.016 409.814 Td /F2 12.0 Tf [()] TJ ET BT 58.016 384.822 Td /F2 12.0 Tf [(Ecz.Arman NEY)] TJ ET BT 58.016 359.829 Td /F2 12.0 Tf [(Genel Sekreter)] TJ ET 0.000 0.000 0.800 rg BT 64.016 334.837 Td 2.860 Tw /F2 12.0 Tf [(T0TCK ) -238 (n1n ) -238 (09.04.2021 ) -238 (Tarih ) -238 (ve ) -238 (E-54398317-510.01.10-398175 ) -238 (Say1l1 ) -238 (yaz1s1na ) -238 (ula_mak ) -238 (iin ) -238 ()] TJ ET 0.000 0.000 0.800 RG 0.468 w 0 J [ ] 0 d 64.016 335.683 m 537.580 335.683 l S BT 58.016 315.845 Td 0.000 Tw /F2 12.0 Tf [(t1klay1n1z.)] TJ ET 0.468 w 0 J [ ] 0 d 58.016 316.691 m 94.856 316.691 l S endstream endobj 8 0 obj << /Type /Font /Subtype /Type1 /Name /F1 /BaseFont /Times-Roman /Encoding /WinAnsiEncoding >> endobj 9 0 obj <> endobj 10 0 obj <> stream /CIDInit /ProcSet findresource begin 12 dict begin begincmap /CIDSystemInfo <> def /CMapName /Adobe-Identity-UCS def /CMapType 2 def 1 begincodespacerange <0000> endcodespacerange 1 beginbfrange <0000> <0000> endbfrange endcmap CMapName currentdict /CMap defineresource pop end endendstream endobj 11 0 obj <> endobj 12 0 obj <> endobj 13 0 obj << /Filter /FlateDecode /Length 221>> stream xNBAFł]W`E$&Bhb}3{&1լIN&I@ew!H1L0Tfc!ˬz52UYrlq qE_R鈛m|9]wnH?>ln;[jEϼ4 $I$I$I$I$I$I$Ij)Wa K endstream endobj 14 0 obj << /Type /FontDescriptor /Flags 32 /FontName /FuturaBT-Light /StemV 70 /Ascent 963 /MissingWidth 963 /Descent -236 /FontBBox [-54 -236 941 963] /ItalicAngle 0.0 /FontFile2 15 0 R >> endobj 15 0 obj << /Length1 11554 /Length 11554 >> stream  0head6hhea$cmap,hmtx2Lmaxp~ glyf%loca)Pname*post, OS/2,Ns*h_<1F1F S 4  )5:IOUZvz01_   (,7AKRXay01^  pkaSN2"s'% {N///NyN9fHb=R}{{mqqNXq9F'^ {TTT\TXXTZ+P+wZTTZ?7j9+ N{mjmj-q\wZ7F?qTZS^H@ ea{9=@9988Fv/7?7jkjkZu>>W=--5{ n/Bw@ 8 ??/..10+7'64/Z:[;wwZklk1i 5y@ ] xv?v?..10+%'DT='y=@ 9$?<<....10+!!L @9 8/?10 +74632#"'&;+*<;++T+;;+)=B9$@ 8"?> ssZip8^ b/[@+# /90 9 9)9 8#8/8&8 )/Fv/7??////<?<<<9....100/+32654&##52654&#"#>32#"'&'&5.,R#)uᲽxx>#&pEi)I~|{{qҩ}&-i7IP_= N@& 89 $8 ] ?32#"&'732654&#"'!!^9p0ݚJh?w©\<)P s䊏MytЯ46q;1@89xv??<<...10+7!5!='q)} /R@' 9 9*98 8-8'8!-'$$8*-Fv/7??/1//?9100-+%2654&#"2654&#".54632#"&546N}}}7m{涺urPwwxw6$yͪq,"Ӓȗ{ @@8 9 9*886xFv/7v??//?.10+4&#"326#"&5432'7s= wmĢ$$|$B^ %@99 8 ??/<<10+74632#"'&4632#"'&;+)>*+;+)><+) T+;;+) +;;+)> j@+8 8889] ?54&'&'.+32#;q%/8=8$6U44HMyl=~-y|/$GX" F(6`ugu2qP%-@%9& 99"8"??/...10&+.# 3267#"$&'.5476$32Nk~VZUl5q?xv8qje%c\\ߑ[U_UU 2$rЍFTictLN!!=@9 988! Fv/7?<UQ>55!5!! 4767>32fXZ܂NQdfdiCT?WHڂZIustXjp9 I@% 9 8 8 Fv/7?54.#"#"$&5476$32c`냀b`:䟝vtqnwP`b`녃^PItrqmpq/Z@, 8  9 9'88 8  Fv/7??Bk%f"%H'>@98Fv/7?32#"&'sQ)lG{{-qj-c22˺_dfc\d5@  9 998??/9...10+.#"3267#"5432V !!Y@, 9(98Fv/7?=#"54325"32654&-~nS  (mi%Չw#-caPV:3 -G,/]nmZPƫʫC@9 8 88 Fv/7?32#4&#"u5O'Z4}nuS,#1L/ 7@ 9 8   Fv/7?32>32#4&#"#4&#"{{+]`%4f{kj~xzfk|wSYXWVY'-'D@9 8 88 Fv/7?32#4&#"u5O'Z4}nuwS,#1Z "-@99 88Fv/7??//10#+%2654&#""&'.54>32;ʓf32ʎ`GCFH`aHILҚi5PsJGCa_IH^`MB E@! 9 9988   Fv/7?32#"&'s1w3R)Z5j6ſ˿75`3feZB I@#9998 8  8  Fv/7?32/"#3CW (*)o{{rat ЛLw?%D@  9&99#8 8 #Fv/7??//99..10&+?32654/.54632.#"#"&?upOM]p~m#qaH@SQfpCILOBeH 6vVp^W??BJ96I+3xjyf L@& 9( 8  Fv/7?GF=epmj1zF ,,--dOIQSqH" DBH"$DB\`d9h@2+* 9781+9:9:! 9'9919'848$98 'Fv/7??/<GF)r)-ԯ13# 9OIQSF ,,--Z"6D;"<D @ 9 ?......10+332673#"&O `YY\ Q A@)?=+*=<+w@ 8?